2134
J. S. Yada6 et al. / Tetrahedron: Asymmetry 12 (2001) 2129–2135
4H), 2.1 (q, J=7 Hz, 2H), 2.4 (m, 4H), 2.8 (t, J=7 Hz,
2H), 3.6 (t, J=7 Hz, 2H), 4.1 (t, J=7 Hz, 2H), 5.2–5.6
(m, 4H). 13C NMR: 13.9, 21, 22.4, 25.6, 26.8, 27.1, 29.2,
31.4, 32, 33.8, 62.1, 63.7, 124.6, 127, 130.5, 131, 172.
EIMS (m/z): 282 (M+).
3H), 1.25–1.45 (m, 8H), 2.1 (q, J=7 Hz, 4H), 2.2 (brs,
1H, -OH), 2.8 (t, J=7 Hz, 2H), 3.65 (t, J=7 Hz, 2H),
5.3–5.6 (m, 4H). 13C NMR: 14, 22.6, 24, 25.9, 27.2, 29.2,
31, 31.7, 63, 125.6, 128, 130.5, 131. EIMS (m/z): 196
(M+).
4.12. 7-Hydroxy-(3Z,5E,7S)-3,5-dodecadienyl 5-hydroxy-
pentanoate 4a
4.16. (5Z,8Z)-5,8-Tetradecadiene-1-ol 10c
1
IR (TF): 3385, 1095 cm−1; H NMR: 0.9 (t, J=7 Hz,
To a homogeneous solution of 1a (100 mg, 0.35 mmol)
in sodium borate buffer (0.2 M, pH 9, 20 mL) at 0°C
was added Lipoxygenase type-1 (50 mg), while O2 was
bubbled through the solution at such a rate to produce
the minimum of foaming. After 1 h the reaction mixture
was acidified with citric acid to pH 5.0, and then
extracted several times with either, dried (NaSO4) and
evaporated to afford the crude hydroperoxide.
3H), 1.25 (m, 6H), 1.4–1.6 (m, 4H), 2.15 (q, J=7 Hz,
4H), 2.25 (brs, 1H, -OH), 2.75 (t, J=7 Hz, 2H), 3.68 (t,
J=7 Hz, 2H), 5.28–5.6 (m, 4H). 13C NMR: 13.8, 22.7,
24.5, 25, 26.1, 27.2, 29, 31, 31.8, 62.5, 125.4, 128, 130.2,
131. EIMS (m/z): 210 (M+).
4.17. (4Z,7Z)-4,7-Tridecadienyl (4-methoxybenzyloxy)-
butanoate 11b
1
The crude hydroperoxide (105 mg) was dissolved in
diethyl ether (2 mL) and the solution cooled in an ice
bath. Triphenylphosphine (TPP, 2 mmol) was added
and the mixture was stirred overnight in an ice bath.
Ether was evaporated to give the crude diol. Chromato-
graphic purification afforded the diol (44 mg, 40%). IR
IR (TF): 1735 cm−1; H NMR: 0.85 (t, J=7 Hz, 3H),
1.35 (brs, 6H), 1.6–1.75 (m, 4H), 2.12 (q, J=7 Hz, 4H),
2.4 (t, J=7 Hz, 2H), 2.75 (t, J=7 Hz, 2H), 3.5 (t, J=7
Hz, 2H), 3.8 (s, 3H), 4.1 (t, J=7 Hz, 2H), 4.5 (s, 2H),
5.2–5.45 (m, 4H), 6.9 (d, J=6 Hz, 2H), 7.2 (d, J=6 Hz,
2H). 13C NMR: 14, 21.3, 22.6, 25.5, 26.7, 27.2, 29.2,
31.5, 32, 34, 62.3m, 64.3, 69.5, 73, 115, 125.8, 128, 129.2,
131, 131.4, 159.2, 179. FABMS: 402 (M+).
1
(TF): 3400, 1740 cm−1; H NMR: 0.9 (t, J=7 Hz, 3H),
1.3 (brs, 6H), 1.5–1.8 (m, 4H), 2.3 (t, J=7 Hz, 2H), 2.4
(t, J=7 Hz, 2H), 2.5 (brs, 2H, -H), 3.6 (t, J=7 Hz, 2H),
4.05 (t, J=7 Hz, 2H), 4.1 (q, J=7 Hz, 1H), 5.46 (dd,
J=7, 10.4 Hz, 1H), 5.73 (dd, J=7, 15 Hz, 1H), 6.15 (dd,
J=10, 10.4 Hz, 1H), 6.52 (dd, J=10, 15 Hz, 1H). 13C
NMR: 14, 20.9, 22.5, 26, 26.9, 27.1, 29.4, 31.6, 34, 62.1,
64, 72, 124, 127.4, 128.5, 130.2, 173. EIMS (m/z): 298
(M+), [h]2D5=+11.0 (c=0.5, CHCl3).
4.18. (5Z,8Z)-5,8-Tetradecadienyl (4-methoxybenzyl-
oxy)propanoate 11c
IR (TF): 1740 cm−1; 1H NMR: 0.9 (t, J=7 Hz, 3H), 1.35
(m, 6H), 1.65 (m, 4H), 2.1 (q, J=7 Hz, 4H), 2.5 (t, J=7
Hz, 2H), 2.78 (t, J=7 Hz, 2H), 3.6 (t, J=7 Hz, 2H), 3.8
(s, 3H), 4.1 (t, J=7 Hz, 2H), 4.5 (s, 2H), 5.25–5.5 (m,
4H), 6.9 (d, J=6 Hz, 2H), 7.2 (d, J=6 Hz, 2H). 13C
NMR: 13.8, 21.4, 22.5, 25.7, 26.4, 27.4, 29.6, 31.5, 32,
33.8, 61.9, 64.7, 69.2, 70.8, 114.6, 125.65, 127.2, 128.5,
129.8, 131.1, 131.6, 160, 180.1. FABMS: 402 (M+).
4.13. (3Z,5E,7S)-3,5-Dodecadiene-1,7-diol 6a
Compound 4a (44 mg, 0.147 mmol) was dissolved in
methanol (2 mL) and the solution treated with KOH (1
g). The mixture was stirred for 12 h at rt and then
diluted with water and extracted several times with
EtOAc. Evaporation and purification by column chro-
matography gave the diol as a yellow oil (30 mg, 90%).
4.19. (4Z,7Z)-4,7-Tridecadienyl 4-hydroxybutanoate 1b
IR (TF): 3385, 1740 cm−1; H NMR: 0.9 (t, J=7 Hz,
1
1
IR (TF): 3400, 980 cm−1; H NMR: 0.85 (t, J=7 Hz,
3H), 1.3 (brs, 6H), 1.6–1.8 (m, 4H), 2.1 (m, 4H), 2.4 (t,
J=7 Hz, 2H), 2.78 (t, J=7 Hz, 2H), 3.65 (t, J=7 Hz,
2H), 4.09 (t, J=7 Hz, 2H), 5.2–5.45 (m, 4H). 13C NMR:
14, 21.1, 22.5, 25.6, 26.4, 27.1, 29.2, 31.4, 32, 33.8, 62.1,
64, 125, 127, 130.5, 131.2, 172. EIMS (m/z): 282 (M+).
3H), 1.26 (m, 6H), 1.44 (m, 2H), 2.2 (brs, 2H, -OH), 2.4
(q, J=7.0 Hz, 2H), 3.69 (t, J=7 Hz, 2H), 4.1 (q J=7
Hz, 1H), 5.46 (dd, J=7, 10.4 Hz, 1H), 5.73 (dd, J=7,
15 Hz, 1H), 6.15 (dd, J=10, 10.4 Hz, 1H), 6.52 (dd,
J=10, 15 Hz, 1H). 13C NMR: 13.9, 22.5, 26, 27, 29.5,
32, 62.5, 65, 124.3, 127.5, 128.6, 130.3. HRMS calcd for
C12H22O2 198.1619 obsd. (m/z) 198.1592 (M+).
4.20. (5Z,8Z)-5,8-Tetradecadienyl 3-hydroxypropanoate
1c
1
4.14. (3R,4E,6Z)-4,6-Dodecadiene-1,3-diol 7a
IR (TF): 3400, 1740 cm−1; H NMR: 0.9 (t, J=7 Hz,
3H), 1.2–1.8 (m, 10H), 2.0 (m, 4H), 2.5 (t, J=7 Hz, 2H),
2.75 (t, J=7 Hz, 2H), 3.8 (t, J=7 Hz, 2H), 4.15 (t, J=7
Hz, 2H), 5.2–5.5 (m, 4H). 13C NMR: 13.9, 21.2, 22.6,
25.5, 26, 27.1, 29.2, 31.4, 32, 34, 34, 62.2, 65.1, 125.1,
127, 131, 131.6, 173. EIMS (m/z): 282 (M+).
1
IR (TF): 3400, 1740 cm−1; H NMR: 0.85 (t, J=7 Hz,
3H), 1.25 (brs, 6H), 1.8 (m, 2H), 2.2 (q, J=7 Hz, 2H),
2.5 (brs, 2H, -OH), 3.8 (m, 2H), 4.4 (q, J=7 Hz, 1H),
5.48 (dd, J=7, 10.4 Hz, 1H), 5.65 (dd, J=7, 15 Hz, 1H),
5.98 (dd, J=10, 10.4 Hz, 1H), 6.52 (dd, J=10, 15 Hz,
1H).
4.21. 8-Hydroxy-(4Z,6E,8S)-4,6-tridecadienyl 4-hydroxy-
butanoate 4b
4.15. (4Z,7Z)-4,7-Tridecadiene-1-ol 10b
1
IR (TF): 3390, 1742 cm−1; H NMR: 0.9 (t, J=7 Hz,
1
IR (TF): 3400, 1090 cm−1; H NMR: 0.9 (t, J=7 Hz,
3H), 1.35 (brs, 6H), 1.6–1.8 (m, 4H), 2.35 (t, J=7 Hz,